| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 168,154 | 215,371 | 100,965 | 111,065 | | Cost of Revenue | 120,703 | 142,278 | 79,054 | 94,246 | | | Gross Profit | 47,451 | 73,093 | 21,911 | 16,819 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 38,618 | 40,529 | 36,884 | 37,284 | | Non Recurring | (219) | (26) | 77 | 9,465 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,052 | 32,590 | (15,050) | (29,930) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 9,052 | 32,590 | (15,050) | (29,930) | | Interest Expense | 87 | 302 | 331 | 403 | | Income Before Tax | 8,965 | 32,288 | (15,381) | (30,333) | | Income Tax Expense | 492 | (200) | 397 | (1,332) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,473 | 32,488 | (15,778) | (29,001) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,473 | 32,488 | (15,778) | (29,001) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,473 | $32,488 | ($15,778) | ($29,001) |
|
0.00% Nasdaq 
Income Statement
